comprehensive -WSS

comprehensive

author：fashion 2025-08-12 06:42:27 - browse：16681

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Medical records are filled with copy
Next article： Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

focus

WSS

How generative AI ratchets up security threats for health systems

In same hospitals, Black patients receive fewer opioids than white patients

Philips to halt sales of sleep apnea machines in U.S.

Wegovy leads to weight loss. Can it treat depression, too?

Venture capital firm's plans to take over Akron hospital face hurdles

American woman, child freed after being kidnapped in Haiti last month

focus

comprehensive

hotspot

Cancer drug shortages should be causing more outrage

Philips to halt sales of sleep apnea machines in U.S.

Hepatitis C has a cure — but many Americans still lack access to it

A biotech analyst on neuroscience, placebo effect, not over

Cancer drug shortages should be causing more outrage

Investment in vaccine development is lagging, report finds

Walensky prepares to leave CDC — and Congress — behind

Vertex non

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

How generative AI ratchets up security threats for health systems

hotspot

Anavex keeps shifting the goalposts in its clinical trials

A biotech analyst on neuroscience, placebo effect, not over

Drastic changes should bring profitability, startup health insurers say

Wegovy’s successful heart trial raises vital question about weight loss

Medicare Advantage insurers face 0.2% cut to 2025 payments

New clues to why women have higher risk of autoimmune disorders

focus

focus

focus

Wikipedia